KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Operations: 2009-2024

Historic Cash from Operations for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to $1.0 billion.

  • Encompass Health's Cash from Operations rose 112.02% to $270.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1614.04%. This contributed to the annual value of $1.0 billion for FY2024, which is 1786.55% up from last year.
  • Latest data reveals that Encompass Health reported Cash from Operations of $1.0 billion as of FY2024, which was up 1786.55% from $850.8 million recorded in FY2023.
  • In the past 5 years, Encompass Health's Cash from Operations ranged from a high of $1.0 billion in FY2024 and a low of $704.7 million during FY2020
  • Over the past 5 years, Encompass Health's median Cash from Operations value was $715.8 million (recorded in 2021), while the average stood at $796.0 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 139.7% in 2022, then surged by 2054.41% in 2023.
  • Encompass Health's Cash from Operations (Annual) stood at $704.7 million in 2020, then increased by 1.58% to $715.8 million in 2021, then dropped by 1.4% to $705.8 million in 2022, then increased by 20.54% to $850.8 million in 2023, then grew by 17.87% to $1.0 billion in 2024.
  • Its Cash from Operations was $1.0 billion in FY2024, compared to $850.8 million in FY2023 and $705.8 million in FY2022.